1. The Better Pharmacare Coalition (BPC). Assessment of a non‐medical switch health policy. Available at:https://betterpharmacare.org/pdfs/Biosimilars_policy%20considerations.pdf. Accessed December 30 2019.
2. British Columbia Ministry of Health. Biosimilars initiative for patients. Available at:https://www2.gov.bc.ca/gov/content/health/health-drug-coverage/pharmacare-for-bc-residents/what-we-cover/drug-coverage/biosimilars-initiative-patients. Accessed September 27 2019.
3. British Columbia Ministry of Health. Biosimilars initiative for pharmacies. Evidence for biosimilar switching. Available at:https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/pharmacare/pharmacies/biosimilars-initiative-pharmacies. Accessed September 27 2019.
4. A rapid monitoring plan following a shift in coverage from brand name to biosimilar drugs for rheumatoid arthritis in British Columbia, 2020;Dormuth CR;Pharmacoepidemiol Drug Saf
5. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis